IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms
Lukas F. Mager(University of Calgary), Philippe Krebs(University of Bern)
Cited by 90
Related Papers
The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer
|Mucosal Immunology|2019|144